BEIJING: China's research unit and a biotech company developed a vaccine for prevention of coronavirus, and the company said Monday that the country's military has approved the medicine for use within its ranks.
Organisations around the world are racing to find ways to treat and prevent the deadly pathogen, which first emerged in the central Chinese city of Wuhan and has since killed over half a million people worldwide.
More than half of 17 candidate vaccines identified by the World Health Organization (WHO) that are in clinical evaluation involve Chinese companies or institutes.
Hong Kong-listed CanSino Biologics said in a filing to the stock exchange that data from clinical trials showed the Chinese military vaccine had a "good safety profile" and potential to prevent disease caused by the novel coronavirus. CanSino said Monday that China's Central Military Commission approved the use of the vaccine on June 25, for one year.
The vaccine was jointly developed by CanSino and the Beijing Institute of Biotechnology, part of the Academy of Military Medical Sciences.
Its use cannot be expanded without further approvals, the listing said.
It was not clear how widely it would be used within China's enormous military forces, and the ministry of defence did not reply to an AFP request for further information.
CanSino added that it cannot guarantee the vaccine — which had its phase one and two clinical trials done in China — will ultimately be commercialised.
Another 131 candidate vaccines listed by the WHO are in the pre-clinical phase.
None have yet been approved for commercial use against the coronavirus.
According to medical journal The Lancet there have already been more than 1,000 clinical trials on dozens of pharmaceutical treatments for the virus but no totally effective medical intervention has been found.
According to the National Institute of Health, the condition of 94 patients with the virus is critical
The WHO chief said the monkeypox outbreak was a deeply concerning evolving threat but did not currently amount to a...
Pakistan's positivity rate rose to 3.19% after 13,644 diagnostic tests were conducted during the last 24 hours
National positivity ratio jumps to 2.22%; Mardan second most affected city with 4.76% positivity
The study says that 19.8 million deaths were prevented out of a potential 31.4 million deaths that would have occurred...
South Africa joins some 40 other countries that have identified patients with the disease